Kuros Biosciences AG

CSBTF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$17,896$17,460$14,277$14,208
Short-Term Investments$0$0$0$0
Receivables$26,886$14,932$9,155$6,411
Inventory$13,712$9,443$6,853$4,856
Other Curr. Assets$2,254$2,919$2,959$1,719
Total Curr. Assets$60,748$44,754$33,244$27,194
Property Plant & Equip (Net)$4,178$3,024$2,941$2,642
Goodwill$24,237$19,433$24,741$24,469
Intangibles$17,574$14,991$16,168$16,508
Long-Term Investments$0$0$0$16,508
Tax Assets$3,194$2,336$0$5,079
Other NC Assets$39$0$209-$16,494
Total NC Assets$49,222$39,784$44,059$48,712
Other Assets$0$0$0$0
Total Assets$109,970$84,538$77,303$75,906
Liabilities
Payables$6,916$6,912$2,828$1,301
Short-Term Debt$653$529$605$578
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$19,422$13,458$8,732$11,308
Total Curr. Liab.$26,991$20,899$12,165$13,187
LT Debt$1,138$1,264$1,359$1,565
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$1,609$331$0$0
Other NC Liab.$3,580$3,296$3,604$3,375
Total NC Liab.$6,327$4,891$4,963$4,940
Other Liabilities$0$0$0$0
Cap. Leases$1,791$1,793$1,964$2,143
Total Liabilities$33,318$25,790$17,128$19,194
Equity
Pref Stock$0$0$0$0
Common Stock$3,152$3,787$3,714$3,678
Retained Earnings-$22,152-$45,427-$42,792-$42,151
AOCI$0$0$0$21,886
Other Equity$95,652$100,388$99,253$73,299
Total Equity$76,652$58,748$60,175$56,712
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$109,970$84,538$77,303$75,906
Net Debt-$16,105-$15,667-$12,313-$12,065
Kuros Biosciences AG (CSBTF) Financial Statements & Key Stats | AlphaPilot